COMPOSITIONS AND METHODS FOR TREATING CLUSTER-TIC SYNDROME

As described below, the present disclosure features compositions containing a cannabidiol (CBD) and/or psilocybin. The present disclosure also features methods for treating or preventing cluster-tic syndrome, or symptoms thereof, with a cannabidiol and/or psilocybin. The present disclosure also feat...

Full description

Saved in:
Bibliographic Details
Main Authors WINGERTZAHN, Mark, CARCILLO, Daniel, JEWELL, Jeffrey, ABBY, Stacey
Format Patent
LanguageEnglish
French
Published 14.12.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:As described below, the present disclosure features compositions containing a cannabidiol (CBD) and/or psilocybin. The present disclosure also features methods for treating or preventing cluster-tic syndrome, or symptoms thereof, with a cannabidiol and/or psilocybin. The present disclosure also features compositions and methods of using psilocybin in combination with a neurotransmitter activity modulator for the treatment cluster-tic syndrome, or comorbidities thereof (e.g., depression). Comme décrit ci-dessous, la présente invention concerne des compositions contenant un cannabidiol (CBD) et/ou une psilocybine. La présente invention concerne également des procédés de traitement ou de prévention du syndrome cluster-tic, ou des symptômes de celui-ci, avec un cannabidiol et/ou une psilocybine. La présente invention concerne également des compositions et des procédés d'utilisation de psilocybine en combinaison avec un modulateur d'activité de neurotransmetteur pour le syndrome de groupe-tic de traitement, ou des comorbidités de celui-ci (par exemple, la dépression).
Bibliography:Application Number: WO2023US20771